click to enlarge picture

C03: HCC and the hepatic vascular niche: Analysis of angiocrine and adhesive vascular targets

The angiogenic activity of hepatocellular carcinoma (HCC) has been correlated with high risk of microvascular invasion, metastasis and poor prognosis. Correspondingly, HCC is among the few tumor types in which anti-angiogenesis has some efficacy as monotherapy. Yet, the overall clinical efficacy is limited and the molecular mechanisms of HCC angiogenesis remain poorly understood. Moreover, no treatment is capable to reduce the high frequency of post-resection HCC recurrence that remains a major clinical concern for the prognosis of HCC. The intrahepatic sinusoidal vasculature has unique organ-specific characteristics with a dual arterial/venous blood supply. It is therefore conceivable that tumor angiogenic processes in HCC are mechanistically different from angiogenesis in other solid tumors including hitherto poorly understood processes of vascular reprogramming termed “capillarization”. To systematically study the mechanisms and therapeutic potential of HCC angiogenesis, the two partnering laboratories have joined forces to exploit their labs’ specific expertise in liver sinusoidal endothelial cell (LSEC) biology (Goerdt laboratory) and tumor angiogenesis (Augustin laboratory) towards a concerted effort to study tumor-vessel interactions during HCC progression and postsurgical recurrence. On the basis of this collaboration, we have thoroughly studied (i) the molecular repertoire of LSEC including angiocrine regulation of liver homeostasis and hepatocyte proliferation as well as (ii) hepatic microvascular reprogramming during hepatocarcinogenesis in a novel preclinical HCC model suitable for proof-of-concept therapy experiments (iAST model). These findings straightforwardly guide the experimental program of project C3: First, we propose to mechanistically study the functional crosstalk between LSEC and HCC cells concentrating on LSEC-specific angiokines (Wnt, Bmp2 and HGF) as well as on candidate molecules for liver-specific HCC-EC adhesion and transmigration (stabilin 2, LYVE-1, and CD44).
Second, we propose to identify and validate known and novel angiocrine and angiogenic factors as vascular targets in HCC and to exploit the therapy-validated iAST model for the systematic and rational preclinical development of novel angio-directed combination therapies. The iAST model will towards this end be advanced to a locally induced tumor model that upon primary tumor removal allows the study of metastasis and recurrence providing the first mouse model recapitulating post-surgical recurrence of human HCC. This advanced tumor model coupled to above mentioned pre-clinical studies (combination therapies) will enable the assessment of the functional role of different candidate molecules in promoting HCC recurrence. Together, the experimental program aims to unravel the complexity of tumor-vessel crosstalk during HCC angiogenesis and microvascular invasion for the preclinical validation and proof-of-principle exploitation of novel therapeutic targets.


Géraud C, Koch PS, Zierow J, Klapproth K, Busch K, Olsavszky V, Leibing T, Demory A, Ulbrich F, Diett M, Singh S, Sticht C, Breitkopf-Heinlein K, Richter K, Karppinen SM, Pihlajaniemi T, Arnold B, Rodewald HR, Augustin HG , Schledzewski K, Goerdt S . (2017) Gata4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopopiesis. J Clin Invest , in press.
Koch PS*, Olsavszky V*, Ulbrich F, Sticht C, Demory A, Leibing T, Henzler T, Meyer M, Zierow J, Schneider S, Breitkopf-Heinlein K, Gaitantzi H, Spencer-Dene B, Arnold B, Klapproth K, Schledzewski K, Goerdt S# , G.raud C# (2016) Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood 2016 Nov 30. pii: blood-2016-07-729822. [Epub ahead of print] (*,# equal contribution).
Mogler C, Wieland M, K.nig C, Hu J, Runge A, Korn C, Besemfelder E, Breitkopf-Heinlein K, Komljenovic D, Dooley S, Schirmacher P , Longerich T, Augustin HG (2015) Hepatic stellate cellexpressed Endosialin balances fibrogenesis and hepatocyte proliferation during liver damage. EMBO Mol Med 7:332-338.
Runge A, Hu J, Wieland M, Bergeest JP, Mogler C, Neumann A, Géraud C, Arnold B, Rohr K, Komljenovic D, Schirmacher P , Goerdt S, Augustin HG (2014) An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice. Cancer Res 74:4157-69.
Hu J, Srivastava K, Wieland M, Runge A, Mogler C, Besemfelder E, Terhardt D, Vogel MJ, Cao L, Korn C, Bartels S, Thomas M, Augustin HG (2014). Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat. Science 343:416-9.
Géraud C, Mogler C, Runge A, Evdokimov K, Lu S, Schledzewski K, Arnold B, Hämmerling G, Koch P, Breuhahn K, Longerich T, Marx A, Weiss C, Schmieder A, Schirmacher P, Augustin HG, Goerdt S (2013) Endothelial transdifferentiation in hepatocellular carcinoma: loss of stabilin-2 expression in peritumorous liver tissue correlates with increased survival. Liver Int 33:1428-40.
Géraud C*, Evdokimov K*, Straub BK, Peitsch WK, Demory A, Dorflinger Y, Schledzewski K, Schmieder A, Schemmer P, Augustin HG, Schirmacher P, Goerdt S (2012) Unique cell type-specific junctional complexes in vascular endothelium of human and rat liver sinusoids. PloS One 7:e34206.
Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, Kutschera S, Bartels S, Appak S, Besemfelder E, Terhardt D, Chavakis E, Wieland T, Klein C, Thomas M, Uemura A, Goerdt S, Augustin HG (2012) Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122:1991-2005.
Schledzewski K*, Géraud C*, Arnold B, Wang S, HJ, Kempf T, Wollert KC, Straub BK, Schirmacher P, Demory A, Schönhaber H, Gratchev A, Dietz L, Thierse HJ, Kzhyshkowska J, Goerdt S (2011) Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin Invest 121:703-14.
Géraud C*, Schledzewski K*, Demory A, Klein D, Kaus M, Peyre F, Sticht C, Evdokimov K, Lu S, Schmieder A, Goerdt S (2010) Liver sinusoidal endothelium: a microenvironment-dependent differentiation program in rat including the novel junctional protein liver endothelial differentiationassociated protein-1. Hepatology 52:313-326.